Daniel C. Baumgart, MD, PhD, MBA

Area of Study / Keywords

IBD Crohn's disease ulcerative colitis celiac disease inflammatory bowel diseases precision medicine precision health digital health artificial intelligence AI immunology autoimmune diseases machine learning decision support ultrasound digital innovation learning health system targeted therapies digital innovation immunology biomedical research digitalization algorithm natural language processing

---

About

Professor Daniel C. Baumgart, MD PhD MBA FEBG FACP FRCP (London) AGAF went to medical school in Berlin, Basel (Switzerland) and Wuerzburg (Bavaria). He received his training in internal medicine, gastroenterology, hepatology and immunology at the Charite and as a German Academic Exchange Service (DAAD) and German Research Foundation (DFG) scholar at the University of Pennsylvania, Philadelphia, PA, Georgetown University, Washington, DC, and the National Institutes of Health (NIH) Bethesda, MD, USA. He is Professor of Medicine at Charite Medical School of the Humboldt-University of Berlin, served as Deputy Chief of the Department of Gastroenterology and Hepatology at Virchow Hospital and elected Fellow at the Berlin Institute of Health (BIH) endowed by the StiftungCharite foundation until 2017 before becoming Chief of the Department of Gastroenterology Hepatology, Infectious Diseases and Rheumatology at Ernst von Bergmann Hospital in 2023. Since 2017 he has been appointed as Full Professor of Medicine at the University of Alberta in Edmonton, Canada. He directed the Division of Gastroenterology until 2022 which under his leadership it reached No. 1 at the University of Alberta, No. 2 in Canada and No. 28 worldwide in the Best Global Universities ranking of U.S. News & World Report. He was Visiting Professor at Yale University, New Haven, CT and Harvard University, Boston, MA, USA. Dr. Baumgart is actively involved in the development of novel diagnostic and therapeutic concepts for Crohn’s disease and ulcerative colitis including new modalities to visualize inflammation, mucosal damage and restitution and image guided intervention as discussed in his 2021 New England Journal of Medicine article. Dr. Baumgart has been principal investigator in some 200 multinational clinical trials and serves co-principal investigator in the Inflammation, Microbiome & Alimentation, Gastro-Intestinal & Neuropsychiatric Effects Specific Patient Oriented Research IMAGINE-SPOR Network funded by the Canadian Institutes of Health Research (CIHR). A trailblazer of digital innovation, Adjunct University Professor of Computing Science, Faculty of Science, Department of Computing Science and member of the Precision Health and AI4Society Signature Areas he has a strong interest in digital health, artificial intelligence (AI) and decision support ultimately aiming to provide precision medicine at the point of care. In a Nature Digital Medicine article he describes how the pandemic accelerates digital innovation in medicine and healthcare. He chaired a Provincial Electronic Health Record (ConnectCare) group and built one of the first Connect Care patient registries in Alberta. Dr. Baumgart is the principal investigator and program director of the „From Data to Decision (FD2D) - Digital Transformation and Artificial Intelligence from Data Value Chain to Human Value“ Collaborative Research and Training Experience (CREATE) program launched in 2022. It unites a multidisciplinary group of researchers and innovators at 22 leading academic institutions and technology companies in North America, Europe and Asia, that develop and study digital transformation and artificial intelligence (AI) applications across various academic disciplines and industrial sectors as well as their impact on society, funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), Mathematics of Information Technology and Complex Systems (Mitacs) and the University of Alberta. Furthermore, his research in collaboration with the Alberta Machine Intelligence Institute, Kule Institute of Advanced Study, and Alberta Health Services received grant support from the Canadian Institute of Advanced Research (CIFAR), Canadian Institutes of Health Research (CIHR), the Social Sciences and Humanities Research Council (SSHRC), the University Hospital Foundation, and Alberta Innovates. In 2023 he was invited by the Federal Minister of Health to lead an interactive session at the international Data for Health conference in Berlin and Follow-Up Workshop at Harvard University alongside top decision makers in society, academia, industry, and government. An invited comment for the U.S. Academy of Sciences journal outlines his perspective on health data integrity. Dr. Baumgart is currently Deputy Editor of Nature Digital Medicine and has been serving on the editorial boards of The Lancet, Gut and Inflammatory Bowel Diseases. He is leading an AI in IBD Working Group of the European Crohn’S and Colitis Organisation (ECCO) and serves on various other national and international panels. A BMW Herbert Quandt Foundation responsible leadership alumnus he developed the integrated clinical and research training curriculum for academic physicians (Clinician Scientist), that received numerous awards including the VolkswagenStiftung foundation's Off the Beaten Track award for its extraordinary design and visionary impetus to academia and has been approved by the German Research Foundation (DFG), Federal Ministry for Education and Research (BMBF), the German Council of Science and Humanities (WR) and adopted by German medical schools nationwide. In 2013, he was appointed Fellow, American College of Physicians (FACP), in 2014 American Gastroenterological Association (AGAF), and in 2017 Royal College of Physicians (FRCP London).

Abraham B.P., Ott E., Busse C., Murphy C., Miller L., Baumgart D.C., Scherl E., Gasink C.

Crohn's and Colitis 360. 2022 July; 4 (3) 10.1093/crocol/otac025

---

Kucharzik T., Atreya R., Bachmann O., Baumgart D.C., Daebritz J., Helwig U., Janschek J., Kienle P., Langhorst J., Mudter J., Schmidt C., Schreyer A.G., Vieth M., Wessling J., Maaser C.

Zeitschrift fur Gastroenterologie. 2022 June; 60 (6):978-990 10.1055/a-1801-0170

---

Abraham B.P., Ott E., Busse C., Murphy C., Miller L., Baumgart D.C., Scherl E., Gasink C.

Crohn's and Colitis 360. 2022 June; 4 (3) 10.1093/crocol/otac025

---

Sutton R.T., Zai?�ane O.R., Goebel R., Baumgart D.C.

Nature Scientific Reports. 2022 February; 12 (1):1 - 10 10.1038/s41598-022-06726-2

---

Balram B., Joshi H., Wong K., Kroeker K.I., Dieleman L.A., Halloran B.P., Baumgart D.C., Peerani F.

Digestive Diseases and Sciences. 2021 November; 66 (11):3985-3992 10.1007/s10620-020-06704-6

---

Julsgaard M., Baumgart D.C., Baunwall S.M.D., Hansen M.M., Grosen A., Bibby B.M., Uldbjerg N., Kjeldsen J., Sørensen H.G., Larsen L., Wildt S., Weimers P., Haderslev K.V., Vind I., Svenningsen L., Brynskov J., Lyhne S., Vestergaard T., Hvas C.L., Kelsen J.

Alimentary Pharmacology and Therapeutics. 2021 November; 54 (10):1320-1329 10.1111/apt.16593

---

Schmidt C., Bachmann O., Baumgart D.C., Goetz M., Drvarov O., Kucharzik T.F., Kühbacher T., Langhorst J., Maul J., Mohl W., Mudter J., Repp M., Sturm A., Witzemann D., Atreya R.

Zeitschrift fur Gastroenterologie. 2021 October; 59 (10):1091-1109 10.1055/a-1504-9782

---

Baumgart D.C., Le Berre C.

New England Journal of Medicine. 2021 September; 385 (14):1302-1315 10.1056/NEJMra1907607

---

Sandborn W.J., Feagan B.G., D'Haens G., Wolf D.C., Jovanovic I., Hanauer S.B., Ghosh S., Petersen A.K., Hua S.Y., Lee J.H., Charles L., Chitkara D., Usiskin K., Colombel J.F., Laine L., Danese S.

NEW ENGLAND JOURNAL OF MEDICINE. 2021 September; 385 (14):1280-1291 10.1056/NEJMoa2033617

---

Winthrop K.L., Loftus E.V., Baumgart D.C., Reinisch W., Nduaka C.I., Lawendy N., Chan G., Mundayat R., Friedman G.S., Salese L., Thorpe A.J., Su C.

J Crohns Colitis. 2021 June; 15 (6):914-929 10.1093/ecco-jcc/jjaa233